在牛皮中蛋白质点和治疗方法:朝着个性化方向
Mohammad Abuzar Shaikh1, Ziyaul Haque1, Anzarul Haque2
1Anjuman-I-Islam's Kalsekar Technical Campus School of Pharmacy, Affiliated to University of Mumbai, New Panvel, 410206, Maharashtra, India.
International immunopharmacology
|August 10, 2025
概括
本综述探讨了牛皮治疗的蛋白质标,包括炎症调节剂,角质细胞生长因子和免疫调节剂. 准这些蛋白质可能会导致针对全球数百万人的慢性皮肤病的个性化疗法.
科学领域:
- 皮肤病学和免疫学
- 分子生物学分子生物学
- 结构生物学 结构生物学
背景情况:
- 牛皮是一种慢性,免疫介导的皮肤疾病,影响全球超过1.25亿人.
- 它的特征是斑块,和,它与诸如牛皮关节炎和心血管疾病等并发症有关.
- 病原发生涉及遗传,环境和免疫因素,导致慢性炎症和角质细胞的过度增殖.
研究的目的:
- 审查与牛皮有关的关键蛋白标的治疗潜力.
- 探索这些蛋白质的结构生物学,以获得药物结合部位的洞察力.
- 突出蛋白质对于开发个性化牛皮治疗策略至关重要.
主要方法:
- 对参与牛皮病原发生的蛋白质的文献综述.
- 分析炎症级联中的蛋白质功能和角质细胞生物学.
- 从蛋白质数据库 (PDB) 检查分子相互作用的结构数据.
主要成果:
- 确定了关键蛋白质:转录调节剂 (ACKR2, NFKBIZ, TNIP1),角质细胞因子 (PK2, KPNA2), kynurenine通路酶 (KYNU, IDO),炎症调解剂 (CXCL10, CYR61) 和抗菌 (LL37, S100A15).
- 这些蛋白质在牛皮病变中显著上调,维持慢性炎症.
- 结构生物学洞察力揭示了分子向的潜在药物结合部位.
结论:
- 像LL37,TNIP1和RORγt这样的蛋白质在牛皮病理学中发挥着独特的作用,这表明了个性化的治疗潜力.
- 将分子向与生物药物相结合,为个性化牛皮治疗提供了一个有希望的途径.
- 这些已识别的蛋白质作为未来干预的潜在生物标记物和治疗点.
相关概念视频
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
01:22iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
01:24Principles of Drug Action
6.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.6K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
254
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
254
01:21EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K